CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Grant or award Director acquired 15,695 shares (grant or award)
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 4 Planned sale Director sold 7,576 shares at an average $22.05 ($167,013)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 227,844 shares at an average $25.14 ($5,728,763)
- 4 Open-market sale Director sold 6,200 shares at $25.30 ($156,860)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
Page 12 of 104 · 2,077 filings